|
|
See Category: Diseases of the musculoskeletal system and connective tissue
ICD-10 (CM) Code and Descriptor
|
M45.0 |
Ankylosing spondylitis of multiple sites in spine
|
M450 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.56%
|
16.67%
|
9.99%
|
6.71%
|
4.46%
|
2.92%
|
1.89%
|
1.41%
|
0.68%
|
0.75%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M45.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,371
|
2,371
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,175
|
2,179
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,161
|
2,167
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,072
|
2,072
|
|
86140
|
C-REACTIVE PROTEIN |
1,898
|
1,898
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,837
|
1,837
|
|
85652
|
RBC SED RATE AUTOMATED |
1,603
|
1,603
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
1,530
|
1,632
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
1,473
|
70,203
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
947
|
1,001
|
|
97110
|
THERAPEUTIC EXERCISES |
871
|
1,532
|
|
J1602
|
GOLIMUMAB FOR IV USE 1MG |
707
|
98,181
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
617
|
618
|
|
82565
|
ASSAY OF CREATININE |
572
|
572
|
|
J0717
|
CERTOLIZUMAB PEGOL INJ 1MG |
530
|
204,412
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
521
|
693
|
|
Q5103
|
INJECTION, INFLECTRA |
455
|
19,506
|
|
85651
|
RBC SED RATE NONAUTOMATED |
448
|
448
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
442
|
528
|
|
85027
|
COMPLETE CBC AUTOMATED |
394
|
394
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M45.0 related to the following DRG Codes:
545-547
|
